Add BrightSurf on Google Email

The heart has its own ‘brain’

Researchers at Karolinska Institutet and Columbia University identified a mini-brain within the heart with its own nervous system that controls the heartbeat. This discovery challenges current views on how the heartbeat is controlled and may lead to new insights into heart diseases and treatments.

SourceKarolinska Institutet·JournalNature Communications·TypeExperimental study·DateDec 4, 2024

With $12 million NIH grant renewal, Lewis Katz School of Medicine researchers to explore novel cell mechanism in heart injury and repair

Researchers at the Lewis Katz School of Medicine will investigate how injured heart cells communicate with other cells throughout the body using microvesicles known as exosomes. The study aims to understand how specific molecules, such as microRNAs, facilitate communication pathways between cells in the heart and vasculature.

ChatGPT fails at heart risk assessment

A study by Washington State University found ChatGPT's generative AI system provided inconsistent heart risk assessments for patients with chest pain. The AI failed to match traditional methods used by physicians and returned different results for the same patient data, highlighting its limitations in high-stakes clinical situations.

SourceWashington State University·JournalPLOS ONE·DateMay 1, 2024

Shorten the blanking period after atrial fibrillation ablation, experts say

Research published in Heart Rhythm suggests that the three-month blanking period after atrial fibrillation (AF) ablation may not be necessary, as early AF recurrence is a predictor of late recurrence. The authors propose shortening the blanking period to one month, citing studies that show higher risks of long-term recurrence for patie...

SourceElsevier·JournalHeart Rhythm·TypeData/statistical analysis·DateApr 17, 2024

Unnecessary use of beta-blockers after a heart attack

A new study published in the New England Journal of Medicine found that half of patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. The study shows that these patients have suffered a small heart attack and have retained heart function afterwards.

SourceKarolinska Institutet·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 8, 2024

Treating anxiety, depression significantly impacts heart disease outcomes

A new study from Ohio State University Wexner Medical Center found that treating anxiety and depression significantly improves heart disease outcomes, with a 75% reduction in hospitalizations or emergency room visits. The study suggests a collaborative care model is essential for managing cardiovascular and mental health.

SourceOhio State University Wexner Medical Center·JournalJournal of the American Heart Association·DateMar 20, 2024

Halting a malformation of the heart

A team of scientists has identified the molecular switches involved in halting heart malformations, which could lead to new treatments for tetralogy of Fallot. By targeting the BBLN protein, they aim to prevent defects in four critical areas of the heart.

SourceETH Zurich·JournalNature Cardiovascular Research·TypeExperimental study·DateNov 22, 2023

In historic procedure, donor liver protects heart transplant

In a groundbreaking procedure, Adriana Rodriguez received a dual-organ transplant, with her healthy liver transplanted into another patient to mitigate rejection risk. This innovative approach, known as HALT-D, demonstrates the potential for immunoprotection and has implications for highly sensitized patients requiring multiple organs.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalThe Journal of Heart and Lung Transplantation·TypeCase study·DateJul 13, 2023

Elevated Lipoprotein(a) is the latest variant of ‘bad cholesterol’ found to increase the risk of recurrent coronary heart disease

A new study found that elevated Lipoprotein(a) levels are a significant predictor of recurrent coronary heart disease (CHD) in people over 60. The study suggests current cholesterol-lowering medications may not be effective in reducing the risk of recurrent CHD, highlighting the need for novel therapeutics to target elevated Lp(a).

SourceTaylor & Francis Group·JournalCurrent Medical Research and Opinion·TypeObservational study·DateJun 13, 2023

A ribosomal traffic jam that breaks the heart

Researchers found that a mutation in RPL3L, expressed only in heart and skeletal muscle, leads to impaired cardiac contractility by causing ribosomal collisions and protein folding abnormalities. The study aims to develop new treatments for cardiomyopathy and atrial fibrillation.

SourceKyushu University·JournalNature Communications·TypeExperimental study·DateMay 18, 2023

National study suggests it’s time to rethink how we treat atrial fibrillation

A national study published in The New England Journal of Medicine finds that early intervention with catheter cryoablation can halt disease progression and reduce serious health risks. Cryoablation is more effective than antiarrhythmic drugs in reducing the risk of persistent AF, hospitalization, and adverse events.

SourceUniversity of British Columbia·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 7, 2022

Heart attack risk increased among people with HIV and hepatitis C as they aged

Research found that people with HIV who also have untreated hepatitis C virus have a higher risk of heart attack as they age. The study analyzed health data from 23,361 people with HIV and found that those co-infected with hepatitis C had a significantly increased risk of heart attack compared to those with HIV alone.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateSep 21, 2022

Many heart-related emergencies are due to uncontrolled blood pressure

A recent study by the American Heart Association highlights that poorly controlled high blood pressure is a leading cause of cardiovascular emergencies in the US. The study analyzed over 20 million emergency department visits and found that 13% were for essential hypertension, which led to hospital admission less than 3% of the time.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateSep 20, 2022

STS/ACC TVT registry analysis assesses use of transcatheter edge-to-edge repair in severe mitral regurgitation and cardiogenic shock

A study using STS/ACC TVT Registry data found that most patients with severe mitral regurgitation (MR) and cardiogenic shock who underwent TEER achieved successful MR reduction, with associated lower mortality and heart failure hospitalizations at one year. Device success was linked to improved survival rates in a high-risk population.

SourceCardiovascular Research Foundation·JournalJournal of the American College of Cardiology·DateSep 17, 2022

Immunotherapy reduces lung and liver fibrosis in mice

Researchers at the University of Zurich have developed a new immunotherapy strategy to eliminate fibroblasts in targeted manner, reducing lung and liver fibrosis in mice. The treatment triggers an immune response via cytotoxic T-cells, eliminating activated connective tissue cells while leaving resting cells undamaged.

SourceUniversity of Zurich·JournalCell Stem Cell·TypeExperimental study·DateSep 15, 2022

Air pollution may spur irregular heart rhythms in healthy teens

A new study published in the Journal of the American Heart Association found that air pollution may trigger irregular heart rhythms in healthy teenagers, with exposure causing arrhythmias to occur within two hours. The research analyzed data from over 300 adolescents and found a significant impact of fine particulate matter on cardiac ...

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateSep 14, 2022

Scientists at the CNIC and Hospital Puerta de Hierro develop a tool to determine if dilated cardiomyopathy has a genetic origin

A new software application predicts the likelihood that a case of dilated cardiomyopathy has a genetic mutation. The Madrid Genotype Score identifies patients most likely to have inherited the disease, facilitating genetic screening and tailored treatment adjustments.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateSep 12, 2022

Dedicated women’s heart centers can improve accurate diagnoses and outcomes

A prospective study in the Canadian Journal of Cardiology found that dedicated women's heart centers can significantly improve clinical and psychological outcomes for women with myocardial ischemia. The study, which followed 154 patients, showed a significant decrease in chest pain frequency and improved quality of life after attending...

SourceElsevier·JournalCanadian Journal of Cardiology·TypeObservational study·DateSep 7, 2022